• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Undescended testes in boyhood linked to testicular cancer and infertility in adulthood

Bioengineer by Bioengineer
August 29, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Led by the University of Sydney researchers and published today in The Lancet Child & Adolescent Health, this is the first population-based cohort study to assess both adult fertility and cancer risk after surgical correction (orchidopexy) for undescended testes in early childhood. The procedure moves an undescended testicle into the scrotum and permanently fixes it there.

"In addition to an increased risk of testicular cancer, we found that boys with undescended testes had decreased paternity and increased use of assisted reproductive technologies for infertility in later life," said the University of Sydney's Professor Natasha Nassar, the study's senior author.

"The study provides new evidence to support international guidelines recommending surgery before 18 months for boys with undescended testes to reduce the risk of both testicular cancer and infertility later in life."

But compliance with these guidelines remains poor with almost half of all boys with undescended testes in Australia and more than three-quarters worldwide being operated on after 18 months, say the research team from the University of Sydney, Curtin University and the Telethon Kids Institute.

"Before this study, there was no evidence-based information on the impact of early surgery on the future risk of testicular cancer and infertility in adult males," said study leader, Dr Francisco Schneuer of the University of Sydney.

"Early diagnosis, ongoing examination and monitoring by parents and health practitioners and timely referral to surgery of boys with undescended testes is important to ensure adherence with guidelines.

"Early surgery can reduce the risk of malignancy and male infertility, and ultimately has the potential to reduce future adult male reproductive disorders."

Study details

This is a population-based cohort study of 350,835 boys born in Western Australia between 1970 and 1999. The cohort was followed until 2016 by linking to data registries for hospital admissions, birth defects, cancer, and assisted reproductive technologies.

Key findings

    + Boys with undescended testes had 2.4 times the risk of adult testicular cancer compared to unaffected boys

    + The risk of testicular cancer increased by 6 percent with each 6-month increase in age at time of surgery (orchidopexy)

    + Boys with undescended testes had a 20 percent lower chance of paternity in adulthood compared to unaffected boys, and were more than twice as likely to use assisted reproductive technology for infertility as adults.

Male reproductive disorders increasing worldwide

    + Undescended testes is the most common reproductive birth defect in infant boys. One in 100 boys are affected and will require surgery

    + Testicular cancer affects young men aged 20-40 years, is the second most common cancer in young men and while rare, has increased by 50 percent in the last 30 years

    + Male infertility is a major challenge, with 5-10 percent of men worldwide being infertile.

###

Media Contact

Dan Gaffney
[email protected]
61-481-004-782
@SydneyUni_Media

http://www.usyd.edu.au/

Share12Tweet7Share2ShareShareShare1

Related Posts

Decoding Prostate Cancer Origins via snFLARE-seq, mxFRIZNGRND

February 7, 2026

Digital Health Perspectives from Baltic Sea Experts

February 7, 2026

Exploring Decision-Making in Dementia Caregivers’ Mobility

February 7, 2026

Succinate Receptor 1 Limits Blood Cell Formation, Leukemia

February 7, 2026
Please login to join discussion

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Decoding Prostate Cancer Origins via snFLARE-seq, mxFRIZNGRND

Digital Health Perspectives from Baltic Sea Experts

Florida Cane Toad: Complex Spread and Selective Evolution

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.